Latest Breaking News On - Idiopathic pulmonary fibrosis - Page 21 : comparemela.com

Artificial Intelligence (AI) in Drug Discovery Market Size & Share to Surpass $7 1 Billion by 2030

WASHINGTON, Nov. 06, 2023 (GLOBE NEWSWIRE) As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the requirement for effective drug development procedures, and partnerships between pharmaceutical companies and AI technology providers. By analyzing enormous volumes of biological and chemical data, AI algorithms and data analytic approaches are revolutionizing

United kingdomUnited statesSouth koreaFacebook youtubeEric kunzClara holoscanAsia pacificInvestment in researchTop companiesAccess to free sample researchDevelopment of the global artificial intelligenceBerg healthCyclica incVantage market researchBiosymetrics incVantage library

Race-Specific Lung-Function Values May Skew IPF Testing

Pulmonary care clinicians may be habitually relying on outdated and inaccurate race-specific reference values when evaluating respiratory impairment in persons of African and Hispanic/Latino ancestry.

New yorkUnited statesJuan wisnievskyAyodeji adegunsoyePulmonary fibrosis foundationHealth equityGlobal lung function initiativeMedscape professional networkNational institutes of healthUniversity of chicagoArtery risk development in young adultsBoehringer ingelheimMount sinai medical centerDiversity committee for the american thoracic societyPulmonary fibrosis foundation patient registryAmerican college of chest physicians

RS BioTherapeutics Promotes Michelle L Shuffett, MD to Chief Medical Officer

RS BioTherapeutics Promotes Michelle L Shuffett, MD to Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDean hartLos angelesMichellel shuffettDavid gutierrezResearch collaboration agreementBoehringer ingelheimUniversity of kentuckyEveryday healthDresner corporate servicesLondon school of economicsSea sprite international ltdTherapeutic expert councilScientific affairsSynapse medical communicationsMillion ways foundation

RS BioTherapeutics Promotes Michelle L Shuffett, MD to

RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer. .

United statesDavid gutierrezMichellel shuffettDean hartLos angelesTherapeutic expert councilResearch collaboration agreementBoehringer ingelheimEveryday healthDresner corporate servicesLondon school of economicsMillion ways foundationSea sprite international ltdUniversity of kentuckySynapse medical communicationsScientific affairs

Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6 6% During the Study Period (2019–2032) | DelveInsight

New York, USA, Oct. 30, 2023 (GLOBE NEWSWIRE) Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (2019–2032) | DelveInsight The overall market of

New yorkUnited statesUnited kingdomMark biosciencesBristol myers squibbShruti thakurNitto denkoVicore pharmaAvalyn pharmaGuangdong raynoventGilead sciencesKadmon corporation llcsPuretech healthMarket researchHealthcare servicesAvalyn pharmaceuticals